D-0104-2021 Class II Terminated
FDA drug recall D-0104-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Nov 6, 2020 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification The recall status is terminated (terminated Mar 23, 2022). Affected quantity: 4,416 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 2, 2020
- Initiation Date
- Nov 6, 2020
- Termination Date
- Mar 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,416 bottles
Product description
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
Reason for recall
Failed Tablet/Capsule Specification
Distribution pattern
Product was distributed nationwide.
Code information
Lot# 20P0141, exp. date 02/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0104-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026